Three 'targeted' cancer drugs raise risk of fatal side effects

Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients.

Read the whole article on Physorg

More from Physorg